These data point to the complexity of managing and treating RDEB, a genetic disease that is associated with loss in ECM organization which is further exacerbated by TGF-β mediated alteration in ECM dynamics. Here, TGFB1 is linked to recessive dystrophic epidermolysis bullosa.